Dr. Ojogho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
105 W 8th Ave
Suite 1000
Spokane, WA 99204Phone+1 509-474-4500Fax+1 509-474-4487
Education & Training
- NorthwesternCertificate, Leading Diversity, Equity, and Inclusion, 2022 - 2022
- Yale University School of ManagementCertificate, Healthcare Management, 2020 - 2020
- University of Southern California, Marshall School of BusinessMMM, Medical Management, 2005 - 2007
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Abdominal Transplant Surgery, 1995 - 1996
- University of ChicagoResidency, Surgery, 1991 - 1994
- University of Washington School of MedicineInternship, Transitional Year, 1986 - 1987
- University of California San Francisco School of MedicineClass of 1986
Certifications & Licensure
- WA State Medical License 1986 - 2027
- CA State Medical License 1994 - 2026
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients Start of enrollment: 2004 Nov 01
- Prospective Donor Specific Antibody (DSA) Monitoring Protocol Start of enrollment: 2011 Aug 01
Publications & Presentations
PubMed
- 11 citationsDisseminated Adenovirus Nephritis After Kidney Transplantation.Timothy Hatlen, Henry Mroch, Katherine R. Tuttle, Okechukwu Ojogho, Michele T. Rooney
Kidney International Reports. 2018-01-01 - 4 citationsPancreaticoduodenectomy in a patient with previous left ventricular assist device: a case report with specific emphasis on peri-operative logistics.Juan Alberto Cosquillo Mejia, Mei Dong, Okechukwu Ojogho
Journal of Surgical Case Reports. 2017-03-01 - 1 citationsEfficacy of Valganciclovir Plus Cytomegalovirus Immune Globulin for Prevention of Cytomegalovirus Disease in High-Risk Renal Transplant RecipientsAngela Q. Maldonado, Amanda N. Bitterman, Okechukwu N. Ojogho, Kurt A Bowen, Douglas L. Weeks
The Annals of Pharmacotherapy. 2014-03-20
Press Mentions
- Local Black Panelists Tackle History-Based Distrust of VaccinesFebruary 20th, 2021
- COVID-19 Vaccinations Begin in Spokane with Sacred Heart Transplant DoctorDecember 18th, 2020
- Transplant Physician Receives Providence’s First COVID-19 VaccineDecember 18th, 2020
Research History
- Research Fellow, The University of ChicagoTransplant Immunobiology- Effect on skin grafts following selective T-cell sub-population deletion with radio-labeled monoclonal antibodies.1988 - 1991
Professional Memberships
- Member
- American Society of Transplant SurgeonsMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: